Usefulness of quantitative assessment of JunB gene expression as a marker for monitoring chronic myeloid leukemia patients undergoing imatinib therapy. (Q54565407)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Usefulness of quantitative assessment of JunB gene expression as a marker for monitoring chronic myeloid leukemia patients undergoing imatinib therapy.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/17189224

Usefulness of quantitative assessment of JunB gene expression as a marker for monitoring chronic myeloid leukemia patients undergoing imatinib therapy. (English)

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/17189224

chronic myeloid leukemia

0 references

1 reference

based on heuristic

inferred from title

author name string

Yi-Chang Liu

1

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/17189224

Hui-Hua Hsiao

2

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/17189224

Jan-Gowth Chang

3

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/17189224

Ming-Yu Yang

4

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/17189224

Ta-Chih Liu

5

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/17189224

Chao-Song Chang

6

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/17189224

Shih-Bin Tseng

7

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/17189224

Huei-Jen Tsai

8

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/17189224

Sheng-Fung Lin

9

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/17189224

publication date

1 December 2006

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/17189224

International Journal of Hematology

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/17189224

84

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/17189224

5

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/17189224

425-431

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/17189224

https://scigraph.springernature.com/pub.10.1532/ijh97.a10514

0 references

The mammalian Jun proteins: redundancy and specificity.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17189224

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Regulation of the c-jun gene in p210 BCR-ABL transformed cells corresponds with activity of JNK, the c-jun N-terminal kinase.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17189224

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serial monitoring of BCR-ABL by peripheral blood real-time polymerase chain reaction predicts the marrow cytogenetic response to imatinib mesylate in chronic myeloid leukaemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/17189224

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical decisions for chronic myeloid leukemia in the imatinib era.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17189224

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Promoter-specific trans-activation and inhibition mediated by JunB.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17189224

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

JunB differs from c-Jun in its DNA-binding and dimerization domains, and represses c-Jun by formation of inactive heterodimers

1 reference

https://pubmed.ncbi.nlm.nih.gov/17189224

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Frequency of major molecular responses to imatinib or interferon alfa plus cytarabine in newly diagnosed chronic myeloid leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/17189224

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Early reduction of BCR-ABL mRNA transcript levels predicts cytogenetic response in chronic phase CML patients treated with imatinib after failure of interferon alpha

1 reference

https://pubmed.ncbi.nlm.nih.gov/17189224

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The molecular biology of chronic myeloid leukemia.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17189224

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chronic myeloid leukemia: current treatment options

1 reference

https://pubmed.ncbi.nlm.nih.gov/17189224

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chronic Myeloid Leukemia with Increased Granulocyte Progenitors in Mice Lacking JunB Expression in the Myeloid Lineage

1 reference

https://pubmed.ncbi.nlm.nih.gov/17189224

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

c-Jun and JunB antagonistically control cytokine-regulated mesenchymal-epidermal interaction in skin

1 reference

https://pubmed.ncbi.nlm.nih.gov/17189224

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Detection of BCR-ABL transcripts in chronic myeloid leukemia (CML) using a 'real time' quantitative RT-PCR assay

1 reference

https://pubmed.ncbi.nlm.nih.gov/17189224

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Aberrantly expressed c-Jun and JunB are a hallmark of Hodgkin lymphoma cells, stimulate proliferation and synergize with NF-kappa B.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17189224

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Monitoring of BCR-ABL expression using real-time RT-PCR in CML after bone marrow or peripheral blood stem cell transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/17189224

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

JunB gene expression is inactivated by methylation in chronic myeloid leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/17189224

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The Bcr-Abl leukemia oncogene activates Jun kinase and requires Jun for transformation

1 reference

https://pubmed.ncbi.nlm.nih.gov/17189224

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Roots of clinical resistance to STI-571 cancer therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/17189224

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The biology of CML blast crisis

1 reference

https://pubmed.ncbi.nlm.nih.gov/17189224

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The mammalian UV response: c-Jun induction is required for exit from p53-imposed growth arrest

1 reference

https://pubmed.ncbi.nlm.nih.gov/17189224

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Imatinib mesylate--a new oral targeted therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/17189224

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chronic Myeloid Leukemia — Advances in Biology and New Approaches to Treatment

1 reference

https://pubmed.ncbi.nlm.nih.gov/17189224

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cell cycle-dependent variations in c-Jun and JunB phosphorylation: a role in the control of cyclin D1 expression.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17189224

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

JunB inhibits proliferation and transformation in B-lymphoid cells.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17189224

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

JunB deficiency leads to a myeloproliferative disorder arising from hematopoietic stem cells.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17189224

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Molecular monitoring of chronic myeloid leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/17189224

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Imatinib induces durable hematologic and cytogenetic responses in patients with accelerated phase chronic myeloid leukemia: results of a phase 2 study

1 reference

https://pubmed.ncbi.nlm.nih.gov/17189224

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

JunB suppresses cell proliferation by transcriptional activation of p16(INK4a) expression

1 reference

https://pubmed.ncbi.nlm.nih.gov/17189224

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Role of alpha1 acid glycoprotein in the in vivo resistance of human BCR-ABL(+) leukemic cells to the abl inhibitor STI571

1 reference

https://pubmed.ncbi.nlm.nih.gov/17189224

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical resistance to STI-571 cancer therapy caused by BCR-ABL gene mutation or amplification

1 reference

https://pubmed.ncbi.nlm.nih.gov/17189224

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A new prognostic score for survival of patients with chronic myeloid leukemia treated with interferon alfa. Writing Committee for the Collaborative CML Prognostic Factors Project Group.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17189224

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Amplification and overexpression of JUNB is associated with primary cutaneous T-cell lymphomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/17189224

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Acquired loss of p53 induces blastic transformation in p210(bcr/abl)-expressing hematopoietic cells: a transgenic study for blast crisis of human CML.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17189224

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Management of chronic myeloid leukemia: targets for molecular therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/17189224

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hematologic and cytogenetic responses to imatinib mesylate in chronic myelogenous leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/17189224

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/17189224

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Imatinib induces hematologic and cytogenetic responses in patients with chronic myelogenous leukemia in myeloid blast crisis: results of a phase II study.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17189224

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Quantitative polymerase chain reaction monitoring of BCR-ABL during therapy with imatinib mesylate (STI571; gleevec) in chronic-phase chronic myelogenous leukemia.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17189224

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Control of cell cycle progression by c-Jun is p53 dependent

1 reference

https://pubmed.ncbi.nlm.nih.gov/17189224

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1532/IJH97.A10514

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/17189224

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/17189224

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54565407&oldid=1584552883"